Calamos Advisors LLC Increases Holdings in Danaher Corporation $DHR

Calamos Advisors LLC lifted its stake in Danaher Corporation (NYSE:DHR) by 18.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 288,363 shares of the conglomerate’s stock after purchasing an additional 44,665 shares during the quarter. Calamos Advisors LLC’s holdings in Danaher were worth $54,674,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. JPL Wealth Management LLC bought a new position in shares of Danaher during the third quarter valued at $25,000. Elevated Capital Advisors LLC purchased a new position in shares of Danaher in the fourth quarter worth approximately $26,000. WFA of San Diego LLC bought a new stake in shares of Danaher during the 2nd quarter valued at $26,000. Hilton Head Capital Partners LLC purchased a new stake in Danaher in the fourth quarter worth about $27,000. Finally, Clal Insurance Enterprises Holdings Ltd increased its holdings in Danaher by 71.6% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after acquiring an additional 53 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Price Performance

Shares of DHR opened at $200.45 on Tuesday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The stock has a market capitalization of $141.87 billion, a PE ratio of 38.77, a PEG ratio of 2.54 and a beta of 0.79. The company has a 50 day moving average price of $181.02 and a 200-day moving average price of $199.06. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same period last year, the business posted $1.88 EPS. The business’s revenue was up 3.7% compared to the same quarter last year. Equities analysts predict that Danaher Corporation will post 8.44 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is currently 30.95%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on DHR shares. Piper Sandler initiated coverage on Danaher in a research note on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price target for the company. JPMorgan Chase & Co. decreased their price target on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. DZ Bank assumed coverage on Danaher in a research note on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price objective for the company. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. Finally, The Goldman Sachs Group dropped their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Monday, April 13th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average price target of $231.64.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.